Company profile
Amicus Therapeutics company profile
Amicus Therapeutics is a biotechnology company that focuses on discovering, developing, and commercializing medicines for rare and genetic diseases. It develops and delivers treatment programs, including oral therapies and combination regimens for specific metabolic conditions such as Fabry and Pompe diseases, and it manages research and licensing activities for additional potential therapies like treatments for focal segmental glomerulosclerosis. The company maintains initiatives that support patient communities affected by rare disorders and collaborates with healthcare and nonprofit organizations to enhance access and advocacy for these disease groups. Amicus also engages in corporate giving programs that support educational, advocacy, and access efforts related to its therapeutic focus areas.
Business identity
- Website
- http://www.amicusrx.com
- Contact email
- [email protected]
- Phone number
- (609)662-200
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 251-500 employees
- Revenue range
- $500,000+
- Founded
- 2002-01-01, Year
Headquarters
- Headquarters
- Cranbury, New Jersey, United States
- Postal code
- 08512
- Country code
- US
- Continent
- North America